Variscite is extending its iMX 8 product portfolio with the new VAR-SOM-MX8X SoM
This highly integrated solution is designed to support a wide range of high-reliability and power-efficient applications, from industrial automation & control to defense, telematics, medical, building control, robotics and failover displays/HMI. The SoM interfaces options and multimedia features include Camera Interfaces, DSI / LVDS, Parallel LCD, Vivante GC7000Lite GPU for 2D and 3D graphics acceleration, 4K H.265 Decode, 1080p H.264 Encode/Decode, dual GbE, certified Wi-Fi/BT, CAN/CAN-FD, USB3.0 and serial interfaces.
Thanks to the integration of ARM’s most efficient Cortex™-A35 cores with its Cortex-M4F real-time co-processor, the VAR-SOM-MX8X offers high processing capabilities in a power-optimized platform.
The VAR-SOM-MX8X is a part of Variscite’s Pin2Pin product family and is pin-compatible with Variscite’s VAR-SOM-MX6, VAR-SOM-SOLO/DUAL and the upcoming VAR-SOM-MX8. By offering Pin2Pin families, Variscite’s customers benefits from a high level of scalability, extended lifetime availability and reduced development time, cost and risk.
Availability and pricing
The VAR-SOM-MX8X Evaluation Kits are now available for early access orders.
VAR-SOM-MX8X key features:
• NXP iMX8X 1.2GHz Dual / Quad Core Cortex™-A35
• Real-time 264MHz Cortex™-M4F co-processor
• Integrated security and fail-safe features
• 24-bit parallel LCD, LVDS/DSI
• 2D/3D graphics acceleration
• Up to 4GB LPDDR4, 64GB eMMC
• 4K H.265 Decode, 1080p H.264 Encode/Decode
• HQ audio in/out
• 2x Gigabit Ethernet, 2x USB 3.0, PCI-E
• Camera in: 1x MIPI-CSI2, 1x parallel CSI 8/10-bit
• Certified Wi-Fi 802.11 ac/a/b/g/n + BT4.2/BLE
• Analog Input, CAN/CAN-FD, UART, SPI, I2C, SD/MMC, Touch
• Temperature range -40 to 85° C
• OS: Linux, Android
• Up to 15 years longevity
For the past 15 years, Variscite has developed, designed and manufactured high-quality System on Modules, consistently setting market benchmarks in terms of reliability, performance, and price. Today Variscite is the leading ARM-based System on Module (SoM) vendor, servicing thousands of satisfied customers worldwide, targeting numerous embedded end products and applications.
4 Hamelacha St. Lod, 7152008 Israel
T: +972 (9) 9562910 | F: +972 (9) 9589477
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Variscite is extending its iMX 8 product portfolio with the new VAR-SOM-MX8X SoM here
News-ID: 1369741 • Views: 886
More Releases from Variscite
Variscite and Foundries.io Partner to Accelerate Development and Management of S …
TEL AVIV, Israel - February 28, 2022 - Variscite, a leading System-on-Module / Computer on Module provider, has integrated its i.MX 8M Mini based System on Modules with Foundries.io's FoundriesFactory cloud-native DevOps service to facilitate OEMs to develop, deploy, manage and update secure IoT and edge devices, enabling them to accelerate time to market while reducing engineering and maintenance costs. The combined Variscite/Founderies.io solution provides a secure, customizable, Linux-based platform
Variscite and Hailo Partner to Provide Out-of-the-Box, Full-Scale, Edge AI Solut …
Variscite's i.MX 8 System on Modules, combined with Hailo's Mini PCIe AI module, enables enterprises to run full-scale deep learning (DL)-based applications more efficiently and sustainably while significantly lowering costs Tel Aviv, Israel, November 08, 2021 - Variscite, a leading global provider of trusted Systems on Module (SoM) solutions for the embedded market, today announced its partnership with leading AI (Artificial Intelligence) chipmaker Hailo to launch a ready-to-use reference platform enabling
More Releases for Decode
Personalized Medicine Market to Witness Huge Growth by 2028 | GE Healthcare, Ill …
Personalized Medicine Market was valued at USD 96.97 Billion in 2021 and is expected to witness a growth of +10% from 2021-2028 and reach USD 217.90 Billion by 2028. Personalized medicine is drugs set based on the response produced by the patient suffering from a particular disease and bring certain biomarkers to cater the requirement of a specific patient. The key objective of personalized medicine is to recognize most appropriate treatment
Decode Your Destiny with the Numerology Name Calculator
Burbank, CA – May 25, 2019 - Trying to decipher your future, get a clearer view of your career and love life? Then why not opt for a free personalized Numerology Reading. Numerology Name Calculator, the world’s largest resource for Astrology enthusiasts, uses the lost art of numerology to find out what your name and birth date say about you. Founded in 2017 by Jeffrey Ito, of numerologynamecalculator.com acts a spiritual guide
Direct-to-Consumer Genetic Testing Devices by 2026 | Major Players 23andMe, Path …
Direct-to-Consumer (DTC) Genetic Testing is advantageous for manufacturers as it gives direct access to them to appeal to the customer and maximize their revenue. However, this testing provides easy access to the customer while chances of misinterpretation are really high. The U.S. FDA has kept these tests in “Tier 3” category due to high chances of misinterpretation of direct-to-consumer (DTC) genetic testing. According to FDA, Tier 3 category means that there
Direct-To-Consumer (DTC) Genetic Testing Market to witness excellent Long-Term G …
Crystal Market Research has announced the addition of "Direct-To-Consumer (DTC) Genetic Testing Market By Sales Channel (Online Sales, Doctor’s Office, OTC Sales) Business Model (Genome Data Bank Material Model, Comprehensive Genome Tests Model, Restricted Trait Tests Model, Individual Health Planning Model, Medical Precision Tests Model) - Global Industry Analysis & Forecast to 2025" Market Research report to their database. Competitive Analysis
Chlamydia Infection Test Market Likely To Boost Future Growth By 2018-2025: Abbo …
The latest research report on the Chlamydia Infection Test market for the forecast period, 2018 – 2025 is involved in screening the business environment and the companies operating in the Chlamydia Infection Test industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on
Direct-to-Consumer Genetic Testing Devices Market 2018 With Major Key Players 23 …
Genetic testing requires patients or healthy individuals to visit trained medical professionals such as doctors, nurses or counselors, in order to get their test interpretations of the result. This process has now become unnecessary or voluntarily with the introduction of direct-to-consumer (DTC) genetic testing devices. This has significantly cut down the cost associated with testing and increasing accessibility of such tests to potential patients. Increasing awareness about health, especially in